Skip to content

Research to compare the effect of three different psychological treatments for irritable bowel syndrome

Individual or group hypnotherapy in the treatment of irritable bowel syndrome in primary and secondary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22888906
Enrollment
354
Registered
2011-06-17
Start date
2011-05-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenterology Digestive System Irritable bowel syndrome (IBS)

Interventions

Patients will be randomly allocated to one of the following: 1. Six sessions of individual hypnotherapy (every 14 days) 2. Six sessions of hypnotherapy in a group consi

Sponsors

University Medical Center Utercht (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years 2. In primary and secondary care 3. Diagnosed with IBS (Rome III criteria)

Exclusion criteria

Exclusion criteria: 1. Patients unable to understand the content of the sessions, because of insufficient command of the Dutch language 2. Patients unable to fill in the questionnaires 3. Patients unable (for example: too agressive) or unwilling to function in a group 4. Patients in whom a psychiatric condition needs attention first (for example severe depression or psychosis) 5. Patients who have IBS in addition to other chronic bowel diseases, as far as they are already diagnosed, such as ulcerative colitis, Crohn's disease or coeliac disease 6. Patients who have undergone major surgery to the lower gastrointestinal tract, such as partial or total colectomy, small bowel resection or partial or total gastrectomy

Design outcomes

Primary

MeasureTime frame
Responder rate for IBS symptoms based on a weekly assessment of Adequate Relief (AR) score.

Secondary

MeasureTime frame
1. Changes in the IBS Symptom Severity Score (IBS-SSS) and Quality of life (IBS-Qol) 2. Cognitions, self-efficacy, psychological complaints and direct and indirect costs of the disease, measured as the costs of visits to doctors and alernative healers, use of medicines and loss of labour productiveness

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026